drugset / Trial / NCT06408246
ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to understand how a psychotropic medication called guanfacine affects brain network functioning in humans, and how this function interacts with cognitive impairments in people experiencing depressive symptoms.
Timeline
- Start
- 2026-03-03
- Primary completion
- 2028-10-01
- Completion
- 2029-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guanfacine | Small molecule | — | — |
| Background | Sertraline | Small molecule | — | — |